Stryker

YTD

ALL

Trade Stryker 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About SYK

Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments.

CEO

Kevin A. Lobo

CEOKevin A. Lobo

Employees

56,000

Employees56,000

Headquarters

Portage, Michigan

HeadquartersPortage, Michigan

Founded

1941

Founded1941

Employees

56,000

Employees56,000

SYK Key Statistics

Market cap

116.77B

Market cap116.77B

Price-Earnings ratio

30.87

Price-Earnings ratio30.87

Dividend yield

1.18%

Dividend yield1.18%

Average volume

2.49M

Average volume2.49M

High today

$305.03

High today$305.03

Low today

$297.18

Low today$297.18

Open price

$301.64

Open price$301.64

Volume

3.17M

Volume3.17M

52 Week high

$392.55

52 Week high$392.55

52 Week low

$267.00

52 Week low$267.00

Stock Snapshot

As of today, Stryker(SYK) shares are valued at $297.21. The company's market cap stands at 116.77B, with a P/E ratio of 30.87 and a dividend yield of 1.18%.

On 2026-10-20, Stryker(SYK) stock moved within a range of $297.18 to $305.03. With shares now at $297.21, the stock is trading +0.0% above its intraday low and -2.6% below the session's peak.

Trading activity shows a volume of 3.17M, compared to an average daily volume of 2.49M.

Over the past 52 weeks, Stryker(SYK) stock has traded between a high of $392.55 and a low of $267.00.

SYK News

Zacks 8h

The Zacks Analyst Blog Highlights Abbott Laboratories, Johnson & Johnson, Stryker, Waste Management and Republic Services

Chicago, IL – October 20, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the l...

Financial Times 16h

The battle of the knee replacement robots - Financial Times

...

Simply Wall St 2d

What Stryker's FDA Clearance Means For Shareholders

Stryker reported that its Sonopet 3 ultrasonic bone and soft tissue removal platform received 510(k) clearance from the U.S. FDA, incorporating surgeon feedback...

Analyst ratings

78%

of 32 ratings

Buy

78.1%

Hold

21.9%

Sell

More SYK News

Simply Wall St 5d

Stryker Wins FDA Clearance, Is The 9% Undervaluation Enough?

Stryker (SYK) has just received 510(k) clearance from the U.S. Food and Drug Administration for Sonopet 3, its latest ultrasonic bone and soft tissue removal pl...

Simply Wall St 6d

Stryker Stock Looks Below Fair Value As Shares Fell 23%

has had a rough stretch on the market over the past year, and the gap between its share price and its underlying cash generation has become a key issue for inve...

TipRanks 6d

Stryker says Sonopet 3 receives FDA 510(k) clearance

Stryker (SYK) announced that Sonopet 3, its latest ultrasonic bone and soft tissue removal platform, has received 510(k) clearance from the U.S. FDA. The first...

People also own

Based on the portfolios of people who own SYK. This list is generated using Robinhood data, and it’s not a recommendation.

Waystar Holding Corp.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.